Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

Concord Biotech Limited (CONCORDBIO.NS)

Compare
1,496.10
-93.20
(-5.86%)
At close: February 28 at 3:30:00 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 2.44B
Earnings 759.21M

Q1'24

Q2'24

Q3'24

Q4'24

0
1B
2B
3B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,620.00
1,906.80 Average
1,496.10 Current
2,187.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----45
Avg. Estimate 0033.6942.7
Low Estimate 003341
High Estimate 0034.946.7
Year Ago EPS --5.729.4533.69

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----44
Avg. Estimate ----11.69B14.18B
Low Estimate ----11.5B13.78B
High Estimate ----11.84B14.97B
Year Ago Sales ----10.17B11.69B
Sales Growth (year/est) ----14.96%21.31%

Earnings History

Currency in INR 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 9.16.57.48.9
EPS Actual 9.085.79.157.26
Difference -0.02-0.81.75-1.64
Surprise % -0.22%-12.31%23.65%-18.43%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0033.6942.7
7 Days Ago 0033.3943.9
30 Days Ago 0035.9146.38
60 Days Ago 0035.7546.83
90 Days Ago 0035.7546.83

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----44
Down Last 30 Days ----23

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CONCORDBIO.NS ----14.41%26.71%
S&P 500 16.00%7.22%10.60%14.10%